Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal with injury or infection. Increasing levels of cortisol increases the blood sugar and can even cause diabetes mellitus. However the disease is also caused due to excess production of hypothalamus corticotropin releasing hormone (CRH) which stimulates the synthesis of cortisol by the adrenal glands.
Cushing’s disease treatment market revenue is growing with a stable growth rate, this is attributed to increasing number of pipeline drugs. Also increasing interest of pharmaceutical companies to develop Cushing disease drugs is a major factor contributing to the revenue growth of Cushing disease treatment market over the forecast period. Current and emerging players’ focuses on physician education and awareness regarding availability of different drugs for curing Cushing disease, thus increasing the referral speeds, time to diagnosis and volume of diagnosed Cushing disease individuals. Growing healthcare expenditure and increasing awareness regarding Cushing syndrome aids in the revenue growth of Cushing’s disease treatment market. Increasing number of new product launches also drives the market for Cushing’s disease Treatment devices. However availability of alternative therapies for curing Cushing syndrome is expected to hamper the growth of the Cushing’s disease treatment market over the forecast period.
The report details the trend, potential and market size of Cushing’s Disease Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cushing’s Disease Treatmentmarket, defines the market attractiveness level of Cushing’s Disease Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cushing’s Disease Treatment industry, describes the types of Cushing’s Disease Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cushing’s Disease Treatment market and the development prospects and opportunities of Cushing’s Disease Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cushing’s Disease Treatment market in Chapter 13.
By Player:
Novartis
CORCEPT THERAPEUTICS
Strongbridge Biopharma
HRA Pharma
By Type:
Ketoconazole
Mitotane
Aminoglutethimide
Metyrapone
Mifepristone
Etomidate
Pasireotide
By End-User:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Clinics
E-Commerce/Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cushing’s Disease Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cushing’s Disease Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cushing’s Disease Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cushing’s Disease Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cushing’s Disease Treatment Market Analysis and Outlook to 2022
-
7.1 Global Cushing’s Disease Treatment Consumption (2017-2022)
-
7.2 United States Cushing’s Disease Treatment Consumption (2017-2022)
-
7.3 Europe Cushing’s Disease Treatment Consumption (2017-2022)
-
7.4 China Cushing’s Disease Treatment Consumption (2017-2022)
-
7.5 Japan Cushing’s Disease Treatment Consumption (2017-2022)
-
7.6 India Cushing’s Disease Treatment Consumption (2017-2022)
-
7.7 South Korea Cushing’s Disease Treatment Consumption (2017-2022)
8 Region and Country-wise Cushing’s Disease Treatment Market Analysis and Outlook to 2028
-
8.1 Global Cushing’s Disease Treatment Consumption Forecast (2022-2028)
-
8.2 United States Cushing’s Disease Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Cushing’s Disease Treatment Consumption Forecast (2022-2028)
-
8.4 China Cushing’s Disease Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Cushing’s Disease Treatment Consumption Forecast (2022-2028)
-
8.6 India Cushing’s Disease Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Cushing’s Disease Treatment Consumption Forecast (2022-2028)
9 Global Cushing’s Disease Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Cushing’s Disease Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ketoconazole Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Mitotane Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Aminoglutethimide Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Metyrapone Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Mifepristone Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Etomidate Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Pasireotide Consumption and Growth Rate (2017-2022)
-
9.2 Global Cushing’s Disease Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drug Stores Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.5 Global E-Commerce/Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Cushing’s Disease Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Cushing’s Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ketoconazole Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Mitotane Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Aminoglutethimide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Metyrapone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Mifepristone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Etomidate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Pasireotide Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cushing’s Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global E-Commerce/Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Cushing’s Disease Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cushing’s Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cushing’s Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cushing’s Disease Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cushing’s Disease Treatment Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Cushing’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Cushing’s Disease Treatment Product and Service
-
14.2 CORCEPT THERAPEUTICS
-
14.2.1 CORCEPT THERAPEUTICS Company Details
-
14.2.2 CORCEPT THERAPEUTICS Cushing’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 CORCEPT THERAPEUTICS Cushing’s Disease Treatment Product and Service
-
14.3 Strongbridge Biopharma
-
14.3.1 Strongbridge Biopharma Company Details
-
14.3.2 Strongbridge Biopharma Cushing’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Strongbridge Biopharma Cushing’s Disease Treatment Product and Service
-
14.4 HRA Pharma
-
14.4.1 HRA Pharma Company Details
-
14.4.2 HRA Pharma Cushing’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 HRA Pharma Cushing’s Disease Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cushing’s Disease Treatment
-
Figure Cushing’s Disease Treatment Picture
-
Table Global Cushing’s Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cushing’s Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cushing’s Disease Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cushing’s Disease Treatment Consumption by Country (2017-2022)
-
Figure United States Cushing’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Cushing’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Cushing’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Cushing’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Cushing’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cushing’s Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Cushing’s Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Cushing’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cushing’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cushing’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cushing’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cushing’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cushing’s Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ketoconazole Consumption and Growth Rate (2017-2022)
-
Figure Global Mitotane Consumption and Growth Rate (2017-2022)
-
Figure Global Aminoglutethimide Consumption and Growth Rate (2017-2022)
-
Figure Global Metyrapone Consumption and Growth Rate (2017-2022)
-
Figure Global Mifepristone Consumption and Growth Rate (2017-2022)
-
Figure Global Etomidate Consumption and Growth Rate (2017-2022)
-
Figure Global Pasireotide Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global E-Commerce/Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Ketoconazole Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mitotane Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aminoglutethimide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metyrapone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mifepristone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Etomidate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pasireotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global E-Commerce/Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cushing’s Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cushing’s Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cushing’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cushing’s Disease Treatment Product and Service
-
Table CORCEPT THERAPEUTICS (Foundation Year, Company Profile and etc.)
-
Table CORCEPT THERAPEUTICS Cushing’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CORCEPT THERAPEUTICS Cushing’s Disease Treatment Product and Service
-
Table Strongbridge Biopharma (Foundation Year, Company Profile and etc.)
-
Table Strongbridge Biopharma Cushing’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strongbridge Biopharma Cushing’s Disease Treatment Product and Service
-
Table HRA Pharma (Foundation Year, Company Profile and etc.)
-
Table HRA Pharma Cushing’s Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table HRA Pharma Cushing’s Disease Treatment Product and Service
-
